X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (812) 812
Publication (38) 38
Book Chapter (18) 18
Conference Proceeding (15) 15
Book / eBook (11) 11
Patent (6) 6
Book Review (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (451) 451
cardiac & cardiovascular systems (368) 368
male (330) 330
female (314) 314
middle aged (248) 248
aged (200) 200
index medicus (163) 163
adult (154) 154
atrial fibrillation (135) 135
electrocardiography (135) 135
risk factors (96) 96
animals (95) 95
cardiology (91) 91
treatment outcome (85) 85
follow-up studies (75) 75
atrial fibrillation - drug therapy (66) 66
mortality (66) 66
prospective studies (64) 64
prognosis (63) 63
anti-arrhythmia agents - therapeutic use (62) 62
arrhythmias (58) 58
catheter ablation (58) 58
heart failure (56) 56
stroke (55) 55
time factors (54) 54
arrhythmia (53) 53
cardiovascular (53) 53
defibrillators, implantable (53) 53
peripheral vascular disease (50) 50
stroke - prevention & control (50) 50
tachycardia (50) 50
atrial fibrillation - complications (49) 49
heart (49) 49
management (49) 49
adolescent (47) 47
electrophysiology (47) 47
risk (45) 45
therapy (45) 45
care and treatment (42) 42
medicine & public health (42) 42
aged, 80 and over (41) 41
prevention (41) 41
cardiac arrhythmia (40) 40
retrospective studies (40) 40
warfarin (40) 40
fibrillation (39) 39
rivaroxaban (39) 39
atrial fibrillation - diagnosis (38) 38
ventricular tachycardia (38) 38
analysis (37) 37
cardiac patients (37) 37
follow-up (35) 35
atrial fibrillation - therapy (34) 34
abridged index medicus (33) 33
cardiac pacing, artificial (33) 33
disease (33) 33
engineering, biomedical (33) 33
heart attacks (33) 33
heart conduction system - physiopathology (33) 33
predictive value of tests (33) 33
anticoagulants (32) 32
prevalence (32) 32
stroke - etiology (31) 31
anticoagulation (30) 30
atrial fibrillation - epidemiology (30) 30
atrial fibrillation - physiopathology (30) 30
mice (30) 30
risk assessment (30) 30
tachycardia, ventricular - physiopathology (30) 30
atrial-fibrillation (29) 29
double-blind method (28) 28
echocardiography (28) 28
long qt syndrome (28) 28
rabbits (28) 28
survival rate (28) 28
cardiomyopathy (27) 27
drug therapy (27) 27
myocardial-infarction (27) 27
repolarization (27) 27
warfarin - administration & dosage (27) 27
heart-failure (26) 26
anticoagulants - administration & dosage (25) 25
heart diseases (25) 25
hematology (25) 25
implantable cardioverter defibrillator (25) 25
sudden cardiac death (25) 25
surgery (25) 25
tachycardia, ventricular - therapy (25) 25
amiodarone (24) 24
anticoagulants - therapeutic use (24) 24
clinical trials (24) 24
diagnosis (24) 24
disease models, animal (24) 24
electrocardiogram (24) 24
survival analysis (24) 24
cardiovascular disease (23) 23
incidence (23) 23
internal medicine (23) 23
long-qt syndrome (23) 23
mutation (23) 23
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


European Heart Journal, ISSN 0195-668X, 07/2019, Volume 40, Issue 28, pp. 2284 - 2286
Journal Article
JACC (Journal of the American College of Cardiology), ISSN 0735-1097, 2013, Volume 61, Issue 19, pp. 1998 - 2006
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 09/2011, Volume 365, Issue 10, pp. 883 - 891
In this trial, 14,264 patients with atrial fibrillation were randomly assigned to receive either rivaroxaban or warfarin. In a per-protocol, as-treated... 
NON-INFERIORITY | ENOXAPARIN | MEDICINE, GENERAL & INTERNAL | DABIGATRAN | STROKE PREVENTION | PHARMACOKINETICS | EFFICACY | ANTITHROMBOTIC THERAPY | PHARMACODYNAMICS | THROMBOPROPHYLAXIS | ANTICOAGULATION | Thiophenes - therapeutic use | Thiophenes - adverse effects | Humans | Middle Aged | Warfarin - adverse effects | Male | Thiophenes - administration & dosage | Warfarin - administration & dosage | Warfarin - therapeutic use | Rivaroxaban | Aged, 80 and over | Female | Stroke - epidemiology | Embolism - epidemiology | Morpholines - adverse effects | Morpholines - therapeutic use | Stroke - prevention & control | Embolism - prevention & control | Double-Blind Method | Administration, Oral | Atrial Fibrillation - drug therapy | Morpholines - administration & dosage | Atrial Fibrillation - complications | Anticoagulants - therapeutic use | Treatment Outcome | Anticoagulants - adverse effects | Intention to Treat Analysis | Aged | Hemorrhage - chemically induced | Stroke (Disease) | Warfarin | Atrial fibrillation | Patient outcomes | Dosage and administration | Drug therapy | Comparative analysis | Risk factors | Fees & charges | Cardiac arrhythmia | Stroke | Heart attacks | Research & development--R&D | Embolisms | Equity | Equity stake | Hemorrhage | Bleeding | Embolism | Studies | Prevention | Fibrillation | Motivation | Ischemia | Thromboembolism | Drug dosages | Pharmaceuticals | Anticoagulants | Morpholines | Life Sciences | Thiophenes | Atrial Fibrillation
Journal Article
European Heart Journal, ISSN 0195-668X, 07/2015, Volume 36, Issue 28, pp. 1794 - 1797
Journal Article
Clinical Research in Cardiology, ISSN 1861-0684, 10/2019
Journal Article
American Heart Journal, ISSN 0002-8703, 2015, Volume 170, Issue 4, pp. 675 - 682.e8
Journal Article
2003, 2nd ed., ISBN 9780879934040, xxiii, 784 p., 32 p. of plates
Book
Book